FDA label
What is Tremfya used for?
Tremfya contains guselkumab. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label for Tremfya lists 4 uses: Plaque Psoriasis; Psoriatic Arthritis; Ulcerative Colitis; Crohn's Disease.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Tremfya?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Tremfya, injection
Indications and Usage, quoted from the label by Janssen Biotech, Inc. (BLA761061). Cross-references to other label sections are left out.
Plaque Psoriasis
TREMFYA is indicated for the treatment of adults and pediatric patients 6 years of age and older who also weigh at least 40 kg with moderate-to-severe plaque psoriasis and who are candidates for systemic therapy or phototherapy.
Psoriatic Arthritis
TREMFYA is indicated for the treatment of adults and pediatric patients 6 years of age and older who also weigh at least 40 kg with active psoriatic arthritis.
Ulcerative Colitis
TREMFYA is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis.
Crohn's Disease
TREMFYA is indicated for the treatment of adult patients with moderately to severely active Crohn's disease.
Source: DailyMed label, set id 1e6dc9ae-1c4c-42d9-87aa-c315ecc51b56, version 29, effective June 4, 2026. NDC 57894-640, one of 3 listings for this product.
Questions
What is Tremfya used for?
The FDA label for Tremfya lists 4 uses: Plaque Psoriasis; Psoriatic Arthritis; Ulcerative Colitis; Crohn's Disease.
What drug class is Tremfya?
FDA lists guselkumab in the Interleukin-23 Antagonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.